Table 5.
Clinical characteristics, use of therapeutic procedures and hospital outcomes after propensity score matching (PSM) for men and women with T2DM hospitalized with STEMI and NSTEMI
| STEMI | NSTEMI | |||||
|---|---|---|---|---|---|---|
| T2DM Men | T2DM Women | p-value | T2DM Men | T2DM Women | p-value | |
| STEMI involving left main coronary artery, n (%) | 41 (0.58) | 32 (0.46) | 0.291 | NA | NA | – |
| STEMI involving left anterior descending coronary artery, n (%) | 768 (10.95) | 689 (9.82) | 0.029 | NA | NA | – |
| STEMI involving other coronary artery of anterior wall, n (%) | 1766 (25.17) | 1796 (25.6) | 0.554 | NA | NA | – |
| STEMI involving right coronary artery, n (%) | 859 (12.24) | 771 (10.99) | 0.021 | NA | NA | – |
| STEMI involving other coronary artery of inferior wall, n (%) | 1687 (24.05) | 1729 (24.64) | 0.403 | NA | NA | – |
| STEMI involving left circumflex coronary artery, n (%) | 96 (1.37) | 94 (1.34) | 0.885 | NA | NA | – |
| STEMI involving other sites, n (%) | 394 (5.62) | 390 (5.56) | 0.886 | NA | NA | – |
| STEMI of unspecified site, n (%) | 1405 (20.03) | 1515 (21.59) | 0.024 | NA | NA | – |
| NSTEMI n (%) | NA | NA | – | 8204 (100) | 8204 (100) | NA |
| Age, mean (SD) | 74.64 (10.77) | 75.87 (11.43) | < 0.001 | 76.26 (9.90) | 76.94 (10.33) | < 0.001 |
| CCI, mean (SD) | 0.74 (0.66) | 0.72 (0.65) | 0.191 | 0.87 (0.85) | 0.83 (0.80) | 0.011 |
| Obesity, n (%) | 1183 (16.86) | 1246 (17.76) | 0.160 | 1561 (19.03) | 1767 (21.54) | < 0.001 |
| Hypertension, n (%) | 4273 (60.9) | 4242 (60.46) | 0.592 | 4699 (57.28) | 4695 (57.23) | 0.950 |
| Lipid metabolism disorders, n (%) | 3945 (56.23) | 3939 (56.14) | 0.919 | 4879 (59.47) | 4944 (60.26) | 0.301 |
| Renal disease, n (%) | 1127 (16.06) | 1159 (16.52) | 0.464 | 1902 (23.18) | 1878 (22.89) | 0.656 |
| Atrial fibrillation, n (%) | 1134 (16.16) | 1217 (17.35) | 0.061 | 1572 (19.16) | 1647 (20.08) | 0.140 |
| Congestive heart failure, n (%) | 1651 (23.53) | 1875 (26.72) | < 0.001 | 2070 (25.23) | 2324 (28.33) | < 0.001 |
| Peripheral vascular disease, n (%) | 320 (4.56) | 310 (4.42) | 0.684 | 491 (5.98) | 548 (6.68) | 0.068 |
| Cerebrovascular disease, n (%) | 347 (4.95) | 376 (5.36) | 0.268 | 420 (5.12) | 487 (5.94) | 0.022 |
| Dementia, n (%) | 204 (2.91) | 334 (4.76) | < 0.001 | 187 (2.28) | 288 (3.51) | < 0.001 |
| Mechanical ventilation, n (%) | 506 (7.21) | 490 (6.98) | 0.599 | 395 (4.81) | 389 (4.74) | 0.826 |
| CABG, n (%) | 84 (1.2) | 52 (0.74) | 0.006 | 266 (3.24) | 209 (2.55) | 0.008 |
| PCI, n (%) | 3813 (54.35) | 3267 (46.56) | < 0.001 | 3222 (39.27) | 2715 (33.09) | < 0.001 |
| LOHS, median (IQR) | 5 (5) | 5.00 (5.00) | 0.121 | 6 (6) | 6.00 (6.00) | 0.467 |
| In-hospital mortality, n (%) | 787 (11.22) | 1095 (15.61) | < 0.001 | 529 (6.45) | 602 (7.34) | 0.025 |
STEMI ST-elevation myocardial infarction, CCI Charlson comorbidity index, CABG coronary artery bypass graft, PCI percutaneous coronary intervention, LOHS length of hospital stay, NA not applicable
The P values for the differences between patients with T2DM and No T2DM were calculated using Student’s t-test, or Mann–Whitney test or chi-square tests